No effect of 50 Hz 2.45 mT magnetic field on the potency of cisplatin, mitomycin C, and methotrexate in S. cerevisiae

Electromagnetic Biology and Medicine

Volumn 27, Issue 3, 2008, Pages 289-297

  Ruiz Gomez M J ^a,b   Merino Moyano, M D ^a   Cebrian Martin M G ^a   Prieto Barcia, M I ^b   Martinez Morillo M ^a  

^a UNIVERSIDAD DE MÁLAGA   (Spain)

^b UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

Cisplatin; Drug resistance; Magnetic fields; Methotrexate; Mitomycin C; S. cerevisiae

Indexed keywords

CHEMOTHERAPY; DRUG DELIVERY; DRUG DOSAGE; EXPERIMENTS; MAGNETIC FIELD MEASUREMENT; MAGNETIC FIELDS; METALLIC MATRIX COMPOSITES; PLATINUM COMPOUNDS;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC DRUGS; CELL-KILLING; CISPLATIN; CONTROLLED CONDITIONS; DROP TESTING; DRUG RESISTANCE; METHOTREXATE; METHOTREXATE (MTX); MITOMYCIN C; S. CEREVISIAE; STRONG CORRELATIONS; TEMPERATURE-SENSITIVE;

MEMBERSHIP FUNCTIONS;

SACCHAROMYCES CEREVISIAE;

ANTINEOPLASTIC AGENT; CISPLATIN; METHOTREXATE; MITOMYCIN;

ARTICLE; CYTOLOGY; DRUG EFFECT; DRUG RESISTANCE; MAGNETISM; SACCHAROMYCES CEREVISIAE; TEMPERATURE;

ANTINEOPLASTIC AGENTS; CISPLATIN; DRUG RESISTANCE, NEOPLASM; MAGNETICS; METHOTREXATE; MITOMYCIN; SACCHAROMYCES CEREVISIAE; TEMPERATURE;

EID: 52949107646     PISSN: 15368378     EISSN: 15368386     Source Type: Journal    
DOI: 10.1080/15368370802277740     Document Type: Article

References (27)

1. Botstein, D., Fink, G. R. (1988). Yeast: and experimental organism for modern biology. Science 240:1439-1443.
2. Cos, J., Bellmunt, J., et al. (2000). Comparative study of sequential combinations of placlitaxel and methotrexate on a human bladder cell line. Cancer Invest. 18:429-435.
3. Florez, J., Armijo, J. A., Mediavilla, A. (1.997). Farmacología Humana, 3rd ed. Barcelona, Masson, S.A.
4. Friedl, A. A., Kiechle, M., et al. (1998). Radiation-induced chromosome aberrations in Saccharomyces cerevisiae: influence of DNA repair pathways. Genetics 148:975-988.
5. Hannan, C. J., Liang, Y., et al. (1994). In vitro cytotoxicity against human cancer cell lines during pulsed magnetic field exposure. Anticancer Res. 14:1517-1520.
6. Harland, J. D., Liburdy, R. P. (1997). Environmental magnetic fields inhibit the antiproliferative action of tamoxifen and melatonin in a human breast cancer cell line. Bioelectromagnetics 18:555-562.
7. Haveman, J., Bergs, J. W., et al. (2005). Effect of hyperthermia on uptake and cytotoxicity of cisplatin in cultured murine mammary carcinoma cells. Oncol. Rep. 14:561-567.
8. IARC (2002). Static and extremely low-frequency (ELF) electric and magnetic fields. In: International Agency for Research on Cancer, Ed. IARC Monographs on the Evaluation of Carcinogenic Risk to Humans, Vol. 80. Lyon.
9. Kusumoto, T., Holden, S. A., et al. (1995). Hyperthermia and platinum complexes: time between treatments and synergy in vitro and in vivo. Int. J. Hyperthermia 11:575-586.
10. Liang, Y., Hannan, C. J., et al. (1997). Enhanced potency of daunorubicin against multidrug resistant subline KB-Ch-8-5-11 by a pulsed magnetic field. Anticancer Res. 17:2083-2088.
11. Loberg, L. I., Luther, M. J., et al. (2000). 60 Hz magnetic fields do not enhance cell killing by genotoxic chemicals in Ataxia telangiectasia and normal, lymphoblastoid cells. Radiat. Res. 153:685-689.
12. Miyagi, N., Sato, K., et al. (2000). Effects of PEMF on a murine osteosarcoma cell line: drug-resistant (P-glycoprotein-positive) and non-resistant cells. Bioelectromagnetics 21:112-121.
13. Novák, J., Stras̃ák, L., et al. (2007). Effects of low-frequency magnetic fields on the viability of yeast Saccharomyces cerevisiae. Bioelectrochemistry 70:115-121.
14. Ohno, S., Siddik, Z. H., et al. (1994). Thermal enhancement of drug uptake and DNA adducts as a possible mechanism, for the effect of sequencing hyperthermia on cisplatin-induced cytotoxicity in L1210 cells. Cancer Chemother. Pharmacol. 34:302-306.
15. Ohtsubo, T., Saito, H., et al. (1997). In vitro effect of hyperthermia on chemoenhancement and uptake of cisplatin in human pharyngeal carcinoma KB cells. Chemotherapy 43:43-50.
16. Okonogi, H., Nakagawa, M., Tsuji, Y. (1996). The effects of a 4.7 tesla static magnetic field on the frequency of micronucleated cells induced by mitomycin C. Tohoku J. Exp. Med. 180:209-215.
17. Omote, Y. (1988). An experimental attempt to potentiate therapeutic effects of combined use of pulsing magnetic fields and antitumor agents. Nippon Geka Gakkai Zasshi 89:1155-1166.
18. Petin, V. G., Kim, J. K., et al. (2002). Some general regularities of synergistic interaction of hyperthermia with various physical and chemical inactivating agents. Int. J. Hyperthermia 18:40-49.
19. Ruiz-Gómez, M. J., de la Peña, L., et al. (2002). Influence of 1 and 25 Hz, 1.5 mT magnetic fields on antitumor drug potency in a human adenocarcinoma cell line. Bioelectromagnetics 23:578-585.
20. Ruiz-Gomez, M. J., Prieto-Barcia, M. L. et al. (2004). Static and 50 Hz magnetic fields of 0.35 and 2.45 mT have no effect on the growth of Saccliaromyces cerevisiae. Bioelectrochemistry 64:151-155.
21. Sabo, J., Mirossay, L., et al. (2002). Effects of static magnetic field on human leukemic cell line H.L-60. Bioelectrochemistry 56:227-231.
22. Scarfi, M. R., Bersani, F., et al. (1991). Spontaneous and mitomycin-C-induced micronuclei in human lymphocytes exposed to extremely low frequency pulsed magnetic fields. Biochem. Biphys. Res. Commun. 176:194-200.
23. Siede, W., Friedl, A. A., et al. (1996). The Saccharomyces cerevisiae Ku autoantigen homologue affects radiosensitivity only in the absence of homologous recombination. Genetics 142:91-102.
24. Souviron Rodríguez, A., Ruiz-Gómez, M. J., et al. (1997). Multirresistencia a drogas (MDR) en Oncología. An. Med. Interna. 14:145-153.
25. Stansell, M. J., Winters, W. D., et al. (2001). Increased antibiotic resistance of E. coli exposed to static magnetic fields. Bioelectromagnetics 22:129-137.
26. Tofani, S., Barone, D., et al. (2003). Static and ELF magnetic fields enhance the in vivo anti-tumor efficacy of cis-platin against lewis lung carcinoma, but not of cyclophosphamide against B16 melanotic melanoma. Pharmacol. Res. 48:83-90.
27. Umezu, K., Sugawara, N., et al. (1998). Genetic analysis of yeast RPA1 reveals its multiple functions in DNA metabolism. Genetics 148:989-1005.